<DOC>
	<DOCNO>NCT01436916</DOCNO>
	<brief_summary>Type 2 diabetes mellitus ( T2DM ) major public health problem .Prevalence vitamin D deficiency also high i.e . 78-96 % different group population north India . Observational study find association low Vitamin D status type 2 diabetes mellitus . Prediabetes condition progress diabetes rate 6-10 % per year .There mechanistic support vitamin D may influence insulin secretion insulin sensitivity subsequently T2DM incidence . In general , cross-sectional prospective study support role vitamin D prevention T2DM . This study single blind randomized placebo control trial study effect oral cholecalciferol insulin sensitivity secretion adult prediabetes also vitamin D insufficient .</brief_summary>
	<brief_title>Oral Cholecalciferol Prevention Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Adults &gt; 20 year Impaired fast glucose ( IFG ) FPG 100125 mg/dl Impaired glucose tolerance ( ( IGT ) 2hr PPG 140199mg/dl OR ( IFG +IGT ) without Hb A1c 5.76.4 % WITH Asymptomatic Vitamin D deficiency ( &lt; 20ng/ml ) vitamin D sufficiency ( &lt; 32ng/ml ) Diabetes mellitus , Base line 25 ( OH ) D3 &gt; 32 ng/ml , Symptomatic vitamin D deficiency , Any medication within last month could affect insulin secretion , insulin sensitivity , vitamin D calcium metabolism Chronic renal , hepatic , malignant , intestinal endocrine disease Febrile illness infective morbidity last 2 week , Grossly derange liver kidney function</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>prediabetes</keyword>
	<keyword>oral cholecalciferol</keyword>
</DOC>